ASSESSING THE EFFICACY AND SAFETY OF MEDICATION GRIPPFERON WITH LORATADINE IN PREVENTING INFLUENZA AND ACUTE RESPIRATORY VIRAL INFECTIONS

Download full text PDF
Issue: 
11
Year: 
2015

S. Ushakova (1), Doctor of Medical Sciences; A. Talaev (2), Doctor of Medical Sciences; O. Chumikov (2); D. Moiseenkov (1) 1 -Kuvaev City Hospital, Ivanovo 2 -Departamental Clinical Hospital at the Ivanovo Station

This paper assesses the efficacy and safety of medication «Grippferon with loratadine», nasal ointment, in preventing acute respiratory viral infections (ARVI) and influenza during epidemics.

Keywords: 
acute respiratory viral infections
influenza
allergic rhinitis
prevention
grippferon with loratadine



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Gaponjuk P.Ja., Kuz'minskaja L.M. «Klinicheskaja i epidemiologicheskaja effektivnost' preparata «Grippferon, kapli v nos» pri ORVI i grippe // Sanitarno-gigienicheskij vestnik. – 2002; 1: 15–8.
  2. Gripp i grippopodobnye infektsii (vkljuchaja osobo opasnye formy grippoznoj infektsii). Fundamental'nye i prikladnye aspekty izuchenija. Bjulleten' problemnoj komissii. Pod red. V.I. Pokrovskogo, D.K. L'vova, O.I. Kiseleva, F.I. Ershova / SPb: Roza mira, 2008; 109: 20.
  3. Hugg T., Ruotsalainen R., Jaakkola M. et al. Comparison of allergic diseases, symptoms and respiratory infections between Finnish and Russian school children // Eur. J. Epidemiol. – 2008; 23 (2): 123–33.
  4. Maleev V.V., Sel'kova E.L., Prostjakov I.V. i dr. Farmakoepidemiologicheskoe issledovanie techenija grippa i drugih ORVI v sezone 2010/2011 gg. // Infektsionnye bolezni. – 2012; 10 (3); 15–24.
  5. Metodicheskie rekomendatsii po lecheniju bol'nyh tjazheloj formoj grippa H1N1 (opyt raboty SPb GUZ Klinicheskaja infektsionnaja bol'nitsa im. S. P. Botkina). Pod red. A.G. Rahmanovoj / SPb, 2009.
  6. Ershov F.I., Kiselev O.I. Interferony i ih induktory (ot molekul do lekarstv) / M.: GEOTAR-Media, 2005; 368.
  7. Berry C., Penhale W., Sangster M. Passive broad-spectrum influenza // Influenza Res. Treat. – 2014; 2014: 267594.
  8. Hellgren J., Cervin A., Nordling S. et al. Allergic rhinitis and the common cold-high cost to society // Allergy. – 2010; 65 (6): 776–83.
  9. Ciprandi G., Tosca M., Fasce L. Allergic children have more numerous and severe respiratory infections than non-allergic children // Pediatr. Allergy Immunol. – 2006; 17 (5): 389–91.
  10. Cirillo I., Marseglia G., Klersy C. et al. Allergic patients have more numerous and prolonged respiratory infections than nonallergic subjects // Allergy. – 2007; 62 (9): 1087–90.
  11. Rantala A., Jaakkola J., Jaakkola M. Respiratory infections in adults with atopic disease and IgE antibodies to common aeroallergens // PLoS One. – 2013; 8 (7): e68582.
  12. De Sutter A., van Driel M., Kumar A. et al. Oral antihistamine-decongestant-analgesic combinations for the common cold // Cochrane Database Syst. Rev. – 2012; 2: CD004976.
  13. Meltzer E., Caballero F., Fromer L. et al. Treatment of congestion in upper respiratory diseases // Int. J. Gen. Med. – 2010; 3: 69–91.
  14. Juldashev A.K., Ivanova A.M., Hodzhaev Sh.H. i dr. Izuchenie profilakticheskoj effektivnosti reaferona pri virusnom gepatite A i ostryh respiratornyh infektsijah u detej // ZhMEI. – 1988; 5: 65.
  15. Chebotareva T.A., Mazankova L.N. Effektivnost' Viferona® v terapii i profilaktike grippa i drugih ORVI u detej // Gazeta «Novosti meditsiny i farmatsii». – 2010; 2 (307): http://www.mif-ua.com|/archive/article_print/1583